PB Leiner jumpstarts new pharma brand gelwoRx™ with two soft capsule specialty products

​Vilvoorde, September 8, 2020 – PB Leiner introduces gelwoRx™, a new product family which it has created to effectively address the needs of the health care sector. The launch is being jumpstarted by the release of two soft capsule specialty products: gelwoRx™ Dsolve enhances the bioavailability of the capsule API by counteracting the natural crosslinking behavior of a capsule shell, while gelwoRx™ Dhydra expedites soft capsule production time. These two products are the first in what will be a whole series of innovative solutions for the sector.